Nature, Published online: 14 July 2025; doi:10.1038/s41586-025-09249-8
A newly identified bacterial strain (YB328) isolated from the faeces of patients who responded to immune checkpoint blockade therapies can promote antitumour immunity through the activation of tumour-specific CD8+ T cells.
From Nature via this RSS feed
You must log in or # to comment.